> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Antimicrobial Drugs Panel to Review Glaxo NDA
- URL: https://www.fdaweb.com/antimicrobial-drugs-panel-to-review-glaxo-nda/
- Published: 2018-06-25T12:00:00.000Z
- Updated: 2026-09-15T00:15:43.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5141765

*Federal Register* notice: FDA has announced a 7/12 Antimicrobial Drugs Advisory Committee meeting. Panel members are scheduled to discuss a GlaxoSmithKline NDA for tafenoquine tablets, 150 mg, indicated for *Plasmodium vivax* malaria relapse prevention. To view the notice, click [here](https://s3.amazonaws.com/public-inspection.federalregister.gov/2018-13710.pdf?ref=fdaweb.com).